Cancer stem cells (CSCs) are cancer cells that possess the ability to undergo continuous proliferation and self-renewal. It has been postulated that CSCs are responsible for tumor growth, heterogeneity, invasion, metastasis, and recurrence. MicroRNAs (miRNAs), small non-coding RNAs of approximately 22 nucleotides, are known to be involved in the maintenance of CSCs. To gain insight into the role of miRNAs in CSCs, we investigated the differential expression of miRNAs in ovarian CSCs compared to non-CSCs. Ovarian CSCs were isolated from the human ovarian cancer cell line SK-OV-3 using two ovarian CSC-specific surface markers, CD44 and CD117. The expression levels of miRNAs in CSCs and non-CSCs were estimated by miRNA sequencing. We detected four up-regulated miRNAs (miR-29a-5p, miR-34c-5p, miR-106a-5p, and miR-424-5p) in ovarian CSCs, and miR-424-5p was validated by real-time qPCR. MiR-424-5p target genes were predicted using several validated target databases and computational algorithms. Pathway analysis indicated that most miR-424-5p target genes are involved in cancer-related biological pathways. Overall, these results suggest that miR-424-5p is a potential regulator of CSCs that endows human ovarian tissue with tumorigenic potential and thus represents a potential therapeutic target for human ovarian cancer.
Ovarian cancer stem cells SK-OV-3 cells microRNA microRNA sequencing
This is a preview of subscription content, log in to check access
This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2012M3A9D1054534), the Hallym University Specialization Fund (HRF-S-11), and an intramural grant from the Korea Institute of Science and Technology (2z04381).
Conflict of interest
The authors declare no conflicts of interest.
In this study, human ovarian cancer cells were obtained from the commercially available human ovary adenocarcinoma (ATCC® HTB-77™). This study was approved by Hallym University Institutional Review Board (HIRB).
Alvero AB, Chen R, Fu HH et al (2009) Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance. Cell Cycle 8:158–166PubMedCentralCrossRefPubMedGoogle Scholar
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185–193CrossRefPubMedGoogle Scholar
Chen D, Zhang Y, Wang J, Chen J, Yang C, Cai K, Wang X, Shi F, Dou J (2013a) MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117 + CD44 + ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J Ovarian Res 6:50PubMedCentralCrossRefPubMedGoogle Scholar
Chen J, Wang J, Chen D, Yang J, Yang C, Zhang Y, Zhang H, Dou J (2013b) Evaluation of characteristics of CD44 + CD117 + ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. BMC Cell Biol 14:7PubMedCentralCrossRefPubMedGoogle Scholar
Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:R60PubMedCentralCrossRefGoogle Scholar
Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354–D357PubMedCentralCrossRefPubMedGoogle Scholar
Luo LJ, Zeng JF, Liang B, Zhao Z, Sun LL, Cao DY, Yang JX, Shen K (2011) Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Exp Mol Pathol 91:596–602CrossRefPubMedGoogle Scholar
Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH, Kwon YD, Lee C, Kim OJ, An HJ (2013) MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res 6:18PubMedCentralCrossRefPubMedGoogle Scholar
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111CrossRefPubMedGoogle Scholar
Zaman MS, Maher DM, Khan S, Jaggi M, Chauhan SC (2012) Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. J Ovarian Res 5:13CrossRefGoogle Scholar
Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang THM, Nephew KP (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68:4311–4320PubMedCentralCrossRefPubMedGoogle Scholar
Zhang D, Shi Z, Li M, Mi J (2014) Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis. Cell Death Dis 5:6Google Scholar